<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="ws1" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">ws1</book-part-id>
      <title-group>
        <title>Waardenburg Syndrome Type I</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Milunsky</surname>
            <given-names>Jeff Mark</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Director, Clinical Genetics<break/>Senior Director, Molecular Genetics<break/>Center Co-Director<break/>Center for Human Genetics, Inc<break/>Cambridge, Massachusetts</aff>
          <email>jmilunsky@chginc.org</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>30</day>
          <month>7</month>
          <year>2001</year>
        </date>
        <date date-type="updated">
          <day>12</day>
          <month>1</month>
          <year>2017</year>
        </date>
        <date date-type="revised">
          <day>4</day>
          <month>5</month>
          <year>2017</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="wfs" document-type="chapter"><italic toggle="yes">WFS1</italic>-Related Disorders</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="weill-ms" document-type="chapter">Weill-Marchesani Syndrome</related-object>
      <abstract id="ws1.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Waardenburg syndrome type I (WS1) is an auditory-pigmentary disorder comprising congenital sensorineural hearing loss and pigmentary disturbances of the iris, hair, and skin, along with dystopia canthorum (lateral displacement of the inner canthi). The hearing loss in WS1, observed in approximately 60% of affected individuals, is congenital, typically non-progressive, either unilateral or bilateral, and sensorineural. Most commonly, hearing loss in WS1 is bilateral and profound (&#x0003e;100 dB). The majority of individuals with WS1 have either a white forelock or early graying of the scalp hair before age 30 years. The classic white forelock observed in approximately 45% of individuals is the most common hair pigmentation anomaly seen in WS1. Affected individuals may have complete heterochromia iridium, partial/segmental heterochromia, or hypoplastic or brilliant blue irides. Congenital leukoderma is frequently seen on the face, trunk, or limbs.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>The diagnosis of WS1 is established in most individuals by physical examination for clinical criteria including: sensorineural hearing loss, pigmentary changes in the hair and eyes, dystopia canthorum identified by calculation of the W index, and specific facial features. Identification of a heterozygous <italic toggle="yes">PAX3</italic> pathogenic variant by molecular genetic testing establishes the diagnosis if clinical features are inconclusive.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Management of the hearing loss depends on its severity; cochlear implantation has been successfully used in individuals with WS1.</p>
          <p><italic toggle="yes">Evaluation of relatives at risk:</italic> If the family-specific <italic toggle="yes">PAX3</italic> pathogenic variant is known, molecular genetic testing of relatives at risk allows for early screening of those at risk for hearing loss.</p>
          <p><italic toggle="yes">Pregnancy management:</italic> Folic acid supplementation in pregnancy is recommended for women at increased risk of having a child with WS1 because of possibly increased risk for neural tube defects in association with WS1.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>Waardenburg syndrome type I (WS1) is inherited in an autosomal dominant manner. The majority of probands have an affected parent. A minority of probands do not have an affected parent and are presumed to have WS1 as a result of a <italic toggle="yes">de novo</italic> pathogenic variant. Offspring of an individual with WS1 have a 50% chance of inheriting the pathogenic variant. If the pathogenic variant has been identified in an affected family member, prenatal testing for pregnancies at increased risk may be available from a clinical laboratory that offers either testing for this disease/gene or custom prenatal testing. Although this testing can determine whether the fetus has inherited the <italic toggle="yes">PAX3</italic> pathogenic variant, it cannot determine the clinical manifestations or their severity.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="ws1.Diagnosis">
        <title>Diagnosis</title>
        <sec id="ws1.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Waardenburg syndrome type I (WS1) <bold>should be suspected</bold> in individuals with several of the following major and minor criteria.</p>
          <p>
            <bold>Major criteria</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Congenital sensorineural hearing loss</p>
            </list-item>
            <list-item>
              <p>White forelock, hair hypopigmentation</p>
            </list-item>
            <list-item>
              <p>Pigmentation abnormality of the iris:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Complete heterochromia iridum (irides of different color)</p>
                </list-item>
                <list-item>
                  <p>Partial/segmental heterochromia (two different colors in same iris, typically brown and blue)</p>
                </list-item>
                <list-item>
                  <p>Hypoplastic blue irides or brilliant blue irides</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Dystopia canthorum, W index &#x0003e;1.95&#x000a0;*</p>
            </list-item>
            <list-item>
              <p>Affected first-degree relative</p>
            </list-item>
          </list>
          <p>
            <bold>Minor criteria</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Skin hypopigmentation (congenital leukoderma)</p>
            </list-item>
            <list-item>
              <p>Synophrys and/or medial eyebrow flare</p>
            </list-item>
            <list-item>
              <p>Broad/high nasal root, low-hanging columella</p>
            </list-item>
            <list-item>
              <p>Underdeveloped alae nasi</p>
            </list-item>
            <list-item>
              <p>Premature gray hair (age &#x0003c;30 years)</p>
            </list-item>
          </list>
          <p>* Note: The measurements necessary to calculate the W index (in mm) are as follows: inner canthal distance (a), interpupillary distance (b), and outer canthal distance (c).</p>
          <p>Calculate X = (2a &#x02013; (0.2119c + 3.909))/cCalculate Y = (2a &#x02013; (0.2479b + 3.909))/bCalculate W = X + Y + a/b</p>
          <p>Click <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="ws1-W_index_calculator.xlsx" content-type="local-data">here</inline-supplementary-material> to download a tool (xlsx) for calculating the W index.</p>
        </sec>
        <sec id="ws1.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of WS1 <bold>is established</bold> in a proband with two major criteria or one major plus two minor criteria (see <xref ref-type="sec" rid="ws1.Suggestive_Findings">Suggestive Findings</xref>) as proposed by the Waardenburg Consortium [<xref ref-type="bibr" rid="ws1.REF.farrer.1992.902">Farrer et al 1992</xref>].</p>
          <p>Identification of a heterozygous pathogenic variant in <italic toggle="yes">PAX3</italic> by molecular genetic testing (see <xref ref-type="table" rid="ws1.T.molecular_genetic_testing_used_in">Table 1</xref>) confirms the diagnosis if clinical features are inconclusive.</p>
          <p>Molecular genetic testing approaches can include <bold>single-gene testing</bold>, <bold>a multi-gene panel</bold>, and <bold>more comprehensive genomic testing</bold>:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Single-gene testing.</bold> Sequence analysis of <italic toggle="yes">PAX3</italic> is performed first and followed by gene-targeted deletion/duplication analysis if no pathogenic variant is found.</p>
            </list-item>
            <list-item>
              <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">PAX3</italic> and other genes of interest (see <xref ref-type="sec" rid="ws1.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: (1) The genes included in the panel and the diagnostic sensitivity of the testing used for each gene vary by laboratory and over time. (2) Some multi-gene panels may include genes not associated with the condition discussed in this <italic toggle="yes">GeneReview</italic>; thus, clinicians need to determine which multi-gene panel provides the best opportunity to identify the genetic cause of the condition at the most reasonable cost while limiting secondary findings. (3) Methods used in a panel may include sequence analysis, deletion/duplication analysis, and/or other non-sequencing based tests.</p>
              <p>For more information on multi-gene panels click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.MultiGene_Panels" object-type="sec">here</related-object>.</p>
            </list-item>
            <list-item>
              <p><bold>More comprehensive genomic testing</bold> (when available) including exome sequencing and genome sequencing may be considered if single-gene testing (and/or use of a multi-gene panel that includes <italic toggle="yes">PAX3</italic>) fails to confirm a diagnosis in an individual with features of WS1. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene or genes that results in a similar clinical presentation). For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
            </list-item>
          </list>
          <table-wrap id="ws1.T.molecular_genetic_testing_used_in" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Molecular Genetic Testing Used in Waardenburg Syndrome Type I</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_ws1.T.molecular_genetic_testing_used_in_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_ws1.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_ws1.T.molecular_genetic_testing_used_in_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_ws1.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">PAX3</italic>
                  </td>
                  <td headers="hd_h_ws1.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_ws1.T.molecular_genetic_testing_used_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;90%&#x000a0;<sup>4</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_ws1.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>5</sup></td>
                  <td headers="hd_h_ws1.T.molecular_genetic_testing_used_in_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">~6%&#x000a0;<sup>6</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="ws1.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="ws1" object-id="ws1.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="ws1.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="ws1.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="ws1.TF.1.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="ws1.TF.1.4">
                <label>4. </label>
                <p><xref ref-type="bibr" rid="ws1.REF.pingault.2010.391">Pingault et al [2010]</xref>, Milunsky [2011, unpublished data], <xref ref-type="bibr" rid="ws1.REF.wildhardt.2013">Wildhardt et al [2013]</xref></p>
              </fn>
              <fn id="ws1.TF.1.5">
                <label>5. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used can include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
              <fn id="ws1.TF.1.6">
                <label>6. </label>
                <p><xref ref-type="bibr" rid="ws1.REF.milunsky.2007.179">Milunsky et al [2007]</xref>. Note: No duplications have been reported.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="ws1.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="ws1.Clinical_Description">
          <title>Clinical Description</title>
          <p>The phenotype of Waardenburg syndrome type I (WS1) is variable even within a family. <xref ref-type="bibr" rid="ws1.REF.liu.1995.95">Liu et al [1995]</xref> summarized the penetrance (percentage) of clinical features of WS1 (see <xref ref-type="table" rid="ws1.T.penetrance_of_individuals_with_waa">Table 2</xref>) in 60 individuals with WS1 and 210 affected individuals reported elsewhere in the literature. <xref ref-type="bibr" rid="ws1.REF.newton.2002.201">Newton [2002]</xref> reviewed the clinical features of the Waardenburg syndromes and <xref ref-type="bibr" rid="ws1.REF.tamayo.2008.1026">Tamayo et al [2008]</xref> discussed their screening program for Waardenburg syndrome in Colombia, detailing the percentage of each clinical manifestation; percentages similar to those found in the <xref ref-type="bibr" rid="ws1.REF.liu.1995.95">Liu et al [1995]</xref> study were documented. However, ascertainment bias was evident, as all 95 affected individuals had hearing loss and were among the institutionalized deaf population in Colombia.</p>
          <table-wrap id="ws1.T.penetrance_of_individuals_with_waa" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p>Penetrance of Individuals with Waardenburg Syndrome Type I with Characteristic Clinical Findings</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_ws1.T.penetrance_of_individuals_with_waa_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Clinical Finding</th>
                  <th id="hd_h_ws1.T.penetrance_of_individuals_with_waa_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">% of Affected Individuals</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_ws1.T.penetrance_of_individuals_with_waa_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Sensorineural hearing loss</td>
                  <td headers="hd_h_ws1.T.penetrance_of_individuals_with_waa_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">47%-58%</td>
                </tr>
                <tr>
                  <td headers="hd_h_ws1.T.penetrance_of_individuals_with_waa_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Heterochromic irides</td>
                  <td headers="hd_h_ws1.T.penetrance_of_individuals_with_waa_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">15%-31%</td>
                </tr>
                <tr>
                  <td headers="hd_h_ws1.T.penetrance_of_individuals_with_waa_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Hypoplastic blue irides</td>
                  <td headers="hd_h_ws1.T.penetrance_of_individuals_with_waa_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">15%-18%</td>
                </tr>
                <tr>
                  <td headers="hd_h_ws1.T.penetrance_of_individuals_with_waa_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">White forelock</td>
                  <td headers="hd_h_ws1.T.penetrance_of_individuals_with_waa_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">43%-48%</td>
                </tr>
                <tr>
                  <td headers="hd_h_ws1.T.penetrance_of_individuals_with_waa_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Early graying</td>
                  <td headers="hd_h_ws1.T.penetrance_of_individuals_with_waa_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">23%-38%</td>
                </tr>
                <tr>
                  <td headers="hd_h_ws1.T.penetrance_of_individuals_with_waa_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Leukoderma</td>
                  <td headers="hd_h_ws1.T.penetrance_of_individuals_with_waa_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">22%-36%</td>
                </tr>
                <tr>
                  <td headers="hd_h_ws1.T.penetrance_of_individuals_with_waa_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">High nasal root</td>
                  <td headers="hd_h_ws1.T.penetrance_of_individuals_with_waa_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">52%-100%</td>
                </tr>
                <tr>
                  <td headers="hd_h_ws1.T.penetrance_of_individuals_with_waa_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Medial eyebrow flare</td>
                  <td headers="hd_h_ws1.T.penetrance_of_individuals_with_waa_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">63%-73%</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Based on <xref ref-type="bibr" rid="ws1.REF.liu.1995.95">Liu et al [1995]</xref>, <xref ref-type="bibr" rid="ws1.REF.pardono.2003.223">Pardono et al [2003]</xref>, <xref ref-type="bibr" rid="ws1.REF.tamayo.2008.1026">Tamayo et al [2008]</xref></p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Hearing loss.</bold> The hearing loss in WS1 is congenital, typically non-progressive, either unilateral or bilateral, and of the sensorineural type. The most common type in WS1 is profound bilateral hearing loss (&#x0003e;100 dB). The laterality of the hearing loss shows both inter- and intrafamilial variation.</p>
          <p>Various temporal bone abnormalities have been identified in persons with WS1 and hearing loss [<xref ref-type="bibr" rid="ws1.REF.madden.2003.2035">Madden et al 2003</xref>]. The temporal bone abnormalities include enlargement of the vestibular aqueduct and upper vestibule, narrowing of the internal auditory canal porus, and hypoplasia of the modiolus.</p>
          <p><bold>Hair color.</bold> The classic white forelock is the most common hair pigmentation anomaly seen in WS1; it may be present at birth, or appear later, typically in the teen years. The white forelock may become normally pigmented over time. The white forelock is typically in the midline but the patch of white hair may also be elsewhere. In evaluating an individual with suspected WS1 without a white forelock, the individual should be asked whether the hair has been dyed. Red and black forelocks have also been described. The majority of individuals with WS1 have either a white forelock or early graying of scalp hair before age 30 years [<xref ref-type="bibr" rid="ws1.REF.farrer.1992.902">Farrer et al 1992</xref>].</p>
          <p>The hypopigmentation can also involve the eyebrows and eyelashes.</p>
          <p><bold>Ocular findings.</bold> Individuals with WS1 may have a variety of ocular pigmentary manifestations. The most commonly observed are complete or segmental heterochromia or hypoplastic or brilliant blue irides. Iris and choroidal hypopigmentation (sector pattern more than diffuse pattern) has been described [<xref ref-type="bibr" rid="ws1.REF.shields.2013.1167">Shields et al 2013</xref>]. Visual acuity does not differ from the general population.</p>
          <p><bold>Skin pigmentation.</bold> Congenital leukoderma (white skin patches) is frequently seen in WS1 on the face, trunk, or limbs. These areas of hypopigmentation frequently have hyperpigmented borders and may be associated with an adjacent white forelock.</p>
          <p><bold>Occasional findings</bold> identified in multiple families (although too few to determine the percentage occurrence in this disorder):</p>
          <list list-type="bullet">
            <list-item>
              <p>Cleft lip and palate</p>
            </list-item>
            <list-item>
              <p>Spina bifida, a finding that is not surprising given that WS1 is considered a neurocristopathy with <italic toggle="yes">PAX3</italic> being expressed in the neural crest. <xref ref-type="bibr" rid="ws1.REF.kujat.2007.155">Kujat et al [2007]</xref> described the prenatal diagnosis of spina bifida in a family with WS1. <xref ref-type="bibr" rid="ws1.REF.lemay.2015.493">Lemay et al [2015]</xref> reported a <italic toggle="yes">de novo</italic> pathogenic nonsense <italic toggle="yes">PAX3</italic> variant in an individual with myelomeningocele and WS1.</p>
            </list-item>
            <list-item>
              <p>Vestibular symptoms including vertigo, dizziness, and balance difficulties, even without hearing loss [<xref ref-type="bibr" rid="ws1.REF.black.2001.188">Black et al 2001</xref>]</p>
            </list-item>
          </list>
          <p><bold>Otopathology.</bold> The otopathology of an individual with WS1 and a <italic toggle="yes">PAX3</italic> pathogenic variant has been described [<xref ref-type="bibr" rid="ws1.REF.merchant.2001.875">Merchant et al 2001</xref>]. The findings are consistent with defective melanocyte migration or function resulting in defective development of the stria vascularis leading to sensorineural hearing loss.</p>
        </sec>
        <sec id="ws1.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p><bold><italic toggle="yes">PAX3.</italic></bold> Genotype/phenotype correlations in <italic toggle="yes">PAX3</italic> are not well established except for the p.Asn47His pathogenic variant, which causes WS3 [<xref ref-type="bibr" rid="ws1.REF.hoth.1993.455">Hoth et al 1993</xref>], and the p.Asn47Lys pathogenic variant described in craniofacial-deafness-hand syndrome [<xref ref-type="bibr" rid="ws1.REF.asher.1996.30">Asher et al 1996</xref>]. <xref ref-type="bibr" rid="ws1.REF.destefano.1998.499">DeStefano et al [1998]</xref> found that the presence of pigmentary disturbances in individuals with WS1 correlated more with <italic toggle="yes">PAX3</italic> pathogenic variants that delete the homeodomain than with missense or deletion pathogenic variants that include the paired domain. No genotype-phenotype correlation for the hearing loss in WS1 has been found.</p>
          <p><bold><italic toggle="yes">PAX3</italic> partial- or whole-gene deletions.</bold> There appears to be no discernable difference in the severity associated with whole- or partial-gene deletions and the clinical spectrum reported for small intragenic <italic toggle="yes">PAX3</italic> pathogenic variants [<xref ref-type="bibr" rid="ws1.REF.milunsky.2007.179">Milunsky et al 2007</xref>].</p>
          <p><bold><italic toggle="yes">PAX3</italic> and <italic toggle="yes">MITF</italic> double heterozygotes (Waardenburg syndrome type I and Waardenburg syndrome type II [WS2] combined phenotype)<italic toggle="yes">.</italic></bold>
<xref ref-type="bibr" rid="ws1.REF.yang.2013.e77149">Yang et al [2013]</xref> reported a family in which one parent had WS1 due to a heterozygous pathogenic variant in <italic toggle="yes">PAX3</italic> and the other parent had WS2 (see <xref ref-type="sec" rid="ws1.Differential_Diagnosis">Differential Diagnosis</xref>) due to a heterozygous pathogenic variant in <italic toggle="yes">MITF</italic>. Their child was heterozygous for both pathogenic variants and had significantly more pigmentary findings (i.e., white forelock, white eyebrows/eyelashes, and leukoderma) than either parent.</p>
        </sec>
        <sec id="ws1.Penetrance">
          <title>Penetrance</title>
          <p>WS1 showed penetrance of at least 85% [<xref ref-type="bibr" rid="ws1.REF.preus.1983.383">Preus et al 1983</xref>] before the advent of molecular testing. Careful examination of individuals identified on the basis of pedigree analysis as having a <italic toggle="yes">PAX3</italic> pathogenic variant usually reveals subtle findings (minor criteria). Hence, those individuals with an affected first-degree relative should be examined closely as the penetrance is likely almost complete.</p>
        </sec>
        <sec id="ws1.Prevalence">
          <title>Prevalence</title>
          <p>It is difficult to quote a figure for the prevalence of WS1 without population-based molecular analysis. The prevalence figures vary from 1:20,000 to 1:40,000, accounting for approximately 3% of congenitally deaf children [<xref ref-type="bibr" rid="ws1.REF.tamayo.2008.1026">Tamayo et al 2008</xref>].</p>
        </sec>
      </sec>
      <sec id="ws1.Genetically_Related_Allelic_Disorder">
        <title>Genetically Related (Allelic) Disorders</title>
        <p><bold>Germline <italic toggle="yes">PAX3</italic> pathogenic variants</bold> also cause the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Waardenburg syndrome type III (WS3) (Klein-Waardenburg syndrome), characterized by a combination of typical WS1 features and hypoplasia or contractures of the limb muscles or joints, carpal bone fusion, or syndactyly [<xref ref-type="bibr" rid="ws1.REF.hoth.1993.455">Hoth et al 1993</xref>]. In a consanguineous Turkish family, both parents who are heterozygous for the <italic toggle="yes">PAX3</italic> p.Tyr90His pathogenic variant have WS1; their child who is homozygous for the p.Tyr90His pathogenic variant has WS3 [<xref ref-type="bibr" rid="ws1.REF.wollnik.2003.42">Wollnik et al 2003</xref>].</p>
          </list-item>
          <list-item>
            <p>Craniofacial-deafness-hand syndrome (CDHS) (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/122880">122880</ext-link>), characterized by a flat facial profile, widely spaced eyes, hypoplastic nose with slit-like nares, and sensorineural hearing loss. X-ray findings include a small maxilla, absent or small nasal bones, and ulnar deviation of the hands [<xref ref-type="bibr" rid="ws1.REF.sommer.2003.91">Sommer &#x00026; Bartholomew 2003</xref>]. <xref ref-type="bibr" rid="ws1.REF.asher.1996.30">Asher et al [1996]</xref> identified a missense variant in <italic toggle="yes">PAX3</italic> in individuals with this disorder. CDHS is apparently distinct from both WS1 and WS3. <xref ref-type="bibr" rid="ws1.REF.gad.2008.1880">Gad et al [2008]</xref> reported a woman who shares some, but not all features of WS3 and CDHS, and who also has abnormal cranial bones (hypoplastic sinuses and small cochlea). Whereas no sequence alteration or whole-gene deletion of <italic toggle="yes">PAX3</italic> was found, partial-gene deletions were not ruled out. The authors suggest genetic heterogeneity even within the CDHS subtype.</p>
          </list-item>
        </list>
      </sec>
      <sec id="ws1.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Waardenburg syndrome type I (WS1) needs to be differentiated from other causes of congenital, non-progressive sensorineural hearing loss (see <related-object link-type="booklink" source-id="gene" document-id="deafness-overview" document-type="chapter">Deafness and Hereditary Hearing Loss Overview</related-object>) and from other forms of Waardenburg syndrome.</p>
        <p><bold>Waardenburg syndrome type II (WS2).</bold> WS1 is distinguished from WS2 by the presence in WS1 of lateral displacement of the inner canthi (dystopia canthorum). If the average W index across a family is less than 1.95, the diagnosis is WS2. Sensorineural hearing loss and heterochromia iridum are the two most characteristic features of WS2. Both are more common in WS2 than WS1. White forelock and leukoderma are both more common in WS1 than in WS2 (see <xref ref-type="table" rid="ws1.T.comparison_of_clinical_features_in">Table 3</xref>).</p>
        <list list-type="bullet">
          <list-item>
            <p><bold><italic toggle="yes">MITF</italic></bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/156845">156845</ext-link>). Heterozygous <italic toggle="yes">MITF</italic> pathogenic variants [<xref ref-type="bibr" rid="ws1.REF.yang.2013.e77149">Yang et al 2013</xref>] have been described in approximately 10%-20% of individuals with WS2. <italic toggle="yes">MITF</italic> pathogenic variants have also been identified in individuals with Tietz syndrome (deafness with uniform hypopigmentation) [<xref ref-type="bibr" rid="ws1.REF.l_ger.2012.584">L&#x000e9;ger et al 2012</xref>].</p>
          </list-item>
          <list-item>
            <p><bold><italic toggle="yes">SOX10</italic></bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/602229">602229</ext-link>). Heterozygous <italic toggle="yes">SOX10</italic> single-nucleotide variants [<xref ref-type="bibr" rid="ws1.REF.iso.2008.2162">Iso et al 2008</xref>] and deletions [<xref ref-type="bibr" rid="ws1.REF.bondurand.2007.1169">Bondurand et al 2007</xref>, <xref ref-type="bibr" rid="ws1.REF.brezo.2014.1512">Brezo et al 2014</xref>] have been described in about 15% of individuals with WS2. <xref ref-type="bibr" rid="ws1.REF.chen.2010.70">Chen et al [2010]</xref> indicated that <italic toggle="yes">SOX10</italic> pathogenic variants occurred with a frequency similar to <italic toggle="yes">MITF</italic> pathogenic variants in individuals with WS2 of Chinese ancestry. Temporal bone abnormalities (specifically bilateral agenesis or hypoplasia of the semicircular canals with a cochlear deformity and enlarged vestibule) are also found in individuals with <italic toggle="yes">SOX10</italic> pathogenic variants [<xref ref-type="bibr" rid="ws1.REF.elmalehberg_s.2013.1257">Elmaleh-Berg&#x000e8;s et al 2013</xref>]. <xref ref-type="bibr" rid="ws1.REF.zhang.2012.491">Zhang et al [2012]</xref> and <xref ref-type="bibr" rid="ws1.REF.chaoui.2011.1436">Chaoui et al [2011]</xref> performed functional analysis of <italic toggle="yes">SOX10</italic> pathogenic variants. A frameshift variant showed a dominant-negative effect on wild type <italic toggle="yes">SOX10</italic>, leading to faster protein decay, possibly resulting in a milder WS2 phenotype [<xref ref-type="bibr" rid="ws1.REF.zhang.2012.491">Zhang et al 2012</xref>].</p>
          </list-item>
          <list-item>
            <p><bold><italic toggle="yes">SNAI2.</italic></bold> Biallelic <italic toggle="yes">SNAI2</italic> pathogenic variants were reported in two individuals with features overlapping WS2 (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/608890">608890</ext-link>)</p>
          </list-item>
        </list>
        <table-wrap id="ws1.T.comparison_of_clinical_features_in" orientation="portrait" position="anchor">
          <label>Table 3. </label>
          <caption>
            <p>Comparison of Clinical Features in WS1 and WS2</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_1">Clinical Finding</th>
                <th id="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_2" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">% of Affected Individuals</th>
              </tr>
              <tr>
                <th headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_2" id="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">WS1</th>
                <th headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_2" id="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">WS2</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Sensorineural hearing loss</td>
                <td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_2 hd_h_ws1.T.comparison_of_clinical_features_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">47%-58%</td>
                <td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_2 hd_h_ws1.T.comparison_of_clinical_features_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">77%-80%</td>
              </tr>
              <tr>
                <td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Heterochromic irides</td>
                <td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_2 hd_h_ws1.T.comparison_of_clinical_features_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">15%-31%</td>
                <td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_2 hd_h_ws1.T.comparison_of_clinical_features_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">42%-54%</td>
              </tr>
              <tr>
                <td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Hypoplastic blue irides</td>
                <td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_2 hd_h_ws1.T.comparison_of_clinical_features_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">15%-18%</td>
                <td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_2 hd_h_ws1.T.comparison_of_clinical_features_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">3%-23%</td>
              </tr>
              <tr>
                <td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">White forelock</td>
                <td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_2 hd_h_ws1.T.comparison_of_clinical_features_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">43%-48%</td>
                <td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_2 hd_h_ws1.T.comparison_of_clinical_features_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">16%-23%</td>
              </tr>
              <tr>
                <td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Early graying</td>
                <td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_2 hd_h_ws1.T.comparison_of_clinical_features_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">23%-38%</td>
                <td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_2 hd_h_ws1.T.comparison_of_clinical_features_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">14%-30%</td>
              </tr>
              <tr>
                <td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Leukoderma</td>
                <td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_2 hd_h_ws1.T.comparison_of_clinical_features_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">22%-36%</td>
                <td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_2 hd_h_ws1.T.comparison_of_clinical_features_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">5%-12%</td>
              </tr>
              <tr>
                <td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">High nasal root</td>
                <td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_2 hd_h_ws1.T.comparison_of_clinical_features_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">52%-100%</td>
                <td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_2 hd_h_ws1.T.comparison_of_clinical_features_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">0%-14%</td>
              </tr>
              <tr>
                <td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Medial eyebrow flare</td>
                <td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_2 hd_h_ws1.T.comparison_of_clinical_features_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">63%-73%</td>
                <td headers="hd_h_ws1.T.comparison_of_clinical_features_in_1_1_1_2 hd_h_ws1.T.comparison_of_clinical_features_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">7%-12%</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Based on <xref ref-type="bibr" rid="ws1.REF.liu.1995.95">Liu et al [1995]</xref>, <xref ref-type="bibr" rid="ws1.REF.pardono.2003.223">Pardono et al [2003]</xref>, <xref ref-type="bibr" rid="ws1.REF.tamayo.2008.1026">Tamayo et al [2008]</xref></p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Waardenburg syndrome type IV (WS4).</bold> Individuals having a rare combination of pigmentary abnormalities, hearing loss, and <related-object link-type="booklink" source-id="gene" document-id="hirschsprung-ov" document-type="chapter">Hirschsprung disease</related-object> have WS4 [<xref ref-type="bibr" rid="ws1.REF.jan.2008.744">Jan et al 2008</xref>] caused by pathogenic variants in one of the following genes: <italic toggle="yes">EDNRB</italic> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/131244">131244</ext-link>), <italic toggle="yes">EDN3</italic> [<xref ref-type="bibr" rid="ws1.REF.ohtani.2006.491">Ohtani et al 2006</xref>] (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/613265">613265</ext-link>), or <italic toggle="yes">SOX10</italic> [<xref ref-type="bibr" rid="ws1.REF.bondurand.2007.1169">Bondurand et al 2007</xref>, <xref ref-type="bibr" rid="ws1.REF.sznajer.2008.1038">Sznajer et al 2008</xref>] (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/602229">602229</ext-link>).</p>
        <p>See Waardenburg syndrome: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/phenotypicSeries/193500">OMIM Phenotypic Series</ext-link> to view genes associated with this phenotype in OMIM.</p>
        <p><bold>Piebaldism</bold> (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/172800">172800</ext-link>). Piebaldism has some pigmentary features in common with Waardenburg syndrome. A white forelock is commonly seen along with absent pigmentation of the medial forehead and eyebrows. Absent pigmentation of the chest, abdomen, and limbs is also common. A characteristic feature is hyperpigmented borders surrounding the unpigmented areas. Heterochromia irides and sensorineural deafness are rarely described. This disorder has shown genetic heterogeneity with dominant loss-of-function variants/whole-gene deletions described involving the <italic toggle="yes">KIT</italic> proto-oncogene. Heterozygous pathogenic variants in <italic toggle="yes">SNAI2</italic> have also been implicated as an etiology in some individuals with piebaldism [<xref ref-type="bibr" rid="ws1.REF.s_nchezmart_n.2003.125">S&#x000e1;nchez-Mart&#x000ed;n et al 2003</xref>].</p>
      </sec>
      <sec id="ws1.Management">
        <title>Management</title>
        <sec id="ws1.Evaluations_Following_Initial_Diagno">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>The following are appropriate:</p>
          <list list-type="bullet">
            <list-item>
              <p>Audiology evaluation</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="ws1.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Management of the hearing loss associated with WS1 depends on its severity (see <related-object link-type="booklink" source-id="gene" document-id="deafness-overview" document-type="chapter">Deafness and Hereditary Hearing Loss Overview</related-object>). Cochlear implantation has been successful in individuals with WS [<xref ref-type="bibr" rid="ws1.REF.amirsalari.2012.2179">Amirsalari et al 2012</xref>, <xref ref-type="bibr" rid="ws1.REF.de_sousa_andrade.2012.1375">de Sousa Andrade et al 2012</xref>, <xref ref-type="bibr" rid="ws1.REF.koyama.2016.2854736">Koyama et al 2016</xref>].</p>
        </sec>
        <sec id="ws1.Surveillance">
          <title>Surveillance</title>
          <p>The hearing loss in WS1 is typically non-progressive. Hence, repeat audiogram would usually not be necessary.</p>
        </sec>
        <sec id="ws1.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>It is appropriate to evaluate at-risk relatives of an affected individual to allow early screening of those at risk for hearing loss. Evaluations can include:</p>
          <list list-type="bullet">
            <list-item>
              <p>Molecular genetic testing if the pathogenic variant in the family is known;</p>
            </list-item>
            <list-item>
              <p>Physical examination for the clinical features of WS1 and audiology evaluation if the pathogenic variant in the family is not known.</p>
            </list-item>
          </list>
          <p>See <xref ref-type="sec" rid="ws1.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="ws1.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>Folic acid supplementation in pregnancy has been recommended for women at increased risk of having a child with WS1, given the possibly increased risk of neural tube defects in association with WS1 [<xref ref-type="bibr" rid="ws1.REF.fleming.1998.2107">Fleming &#x00026; Copp 1998</xref>]; however, no human studies have addressed the ideal dose of folic acid to be used during pregnancy.</p>
        </sec>
        <sec id="ws1.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="ws1.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="ws1.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Waardenburg syndrome type I (WS1) is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="ws1.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The majority of individuals diagnosed with WS1 have an affected parent.</p>
            </list-item>
            <list-item>
              <p>A minority of individuals diagnosed with WS1 do not have an affected parent and are presumed to have a <italic toggle="yes">de novo</italic> pathogenic variant. The mutation rate has been estimated at 0.4 per 100,000 [<xref ref-type="bibr" rid="ws1.REF.waardenburg.1951.195">Waardenburg 1951</xref>]. <xref ref-type="bibr" rid="ws1.REF.jones.1975.84">Jones et al [1975]</xref> found evidence of advanced paternal age effect in <italic toggle="yes">de novo</italic> pathogenic variants of WS1.</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant include examination for clinical manifestations of WS1 by: assessing the facial features, calculating the W index, examining the skin and hair for hypopigmentation, and obtaining an audiogram.</p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant found in the proband cannot be detected in leukocyte DNA of either parent, possible explanations include a <italic toggle="yes">de novo</italic> pathogenic variant in the proband or germline mosaicism in a parent (germline mosaicism has been reported [<xref ref-type="bibr" rid="ws1.REF.kapur.1991.194">Kapur &#x00026; Karam 1991</xref>]).</p>
            </list-item>
            <list-item>
              <p>Evaluation of parents may determine that one is affected but has escaped previous diagnosis because of a milder phenotypic presentation. Therefore, an apparently negative family history cannot be confirmed until appropriate evaluations have been performed.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband's parents.</p>
            </list-item>
            <list-item>
              <p>If a parent of the proband is affected or has a <italic toggle="yes">PAX3</italic> pathogenic variant, the risk to the sibs is 50%.</p>
            </list-item>
            <list-item>
              <p>When the parents are clinically unaffected, the risk to sibs of a proband is low.</p>
            </list-item>
            <list-item>
              <p>If the <italic toggle="yes">PAX3</italic> pathogenic variant found in the proband cannot be detected in the leukocyte DNA of either parent, the risk to sibs is slightly greater than that of the general population because of the possibility of parental germline mosaicism [<xref ref-type="bibr" rid="ws1.REF.kapur.1991.194">Kapur &#x00026; Karam 1991</xref>].</p>
            </list-item>
          </list>
          <p>
            <bold>Offspring of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Each child of an individual with WS1 has a 50% chance of inheriting the pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>The clinical manifestations in the offspring cannot be predicted and range from mild or subclinical features through the classic phenotype of WS1, including deafness.</p>
            </list-item>
          </list>
          <p><bold>Other family members.</bold> The risk to other family members depends on the status of the proband's parents: if a parent is affected, his or her family members are at risk.</p>
        </sec>
        <sec id="ws1.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="ws1.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with an autosomal dominant condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <italic toggle="yes">de novo</italic>. However, non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk of being affected.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="ws1.Prenatal_Testing_and_Preimplantation">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">PAX3</italic> pathogenic variant has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for WS1 are possible. Although such testing can determine whether the <italic toggle="yes">PAX3</italic> pathogenic variant has been inherited, the results of such testing cannot be used to predict clinical manifestations or their severity.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="ws1.Resources">
        <title>Resources</title>
      </sec>
      <sec id="ws1.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="ws1.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p><italic toggle="yes">PAX3</italic> is one of a family of nine human <italic toggle="yes">PAX</italic> genes coding for DNA-binding transcription factors that are expressed in the early embryo. The <italic toggle="yes">PAX</italic> genes are defined by the presence of a paired box (128-amino acid DNA-binding domain). In addition, <italic toggle="yes">PAX3</italic> contains a homeobox [<xref ref-type="bibr" rid="ws1.REF.birrane.2009.1148">Birrane et al 2009</xref>].</p>
          <p><bold>Gene structure.</bold>
<italic toggle="yes">PAX3</italic> has a number of transcript variants that encode different isoforms (see <related-object source-id="gene" document-id="ws1" object-id="ws1.molgen.TA">Table A</related-object>, <bold>Gene</bold>). <italic toggle="yes">PAX3</italic> has ten exons, with the paired box in exons 2-4 and the homeobox in exons 5 and 6 [<xref ref-type="bibr" rid="ws1.REF.birrane.2009.1148">Birrane et al 2009</xref>], and encodes paired box protein Pax-3.</p>
          <p><bold>Pathogenic variants.</bold> Pathogenic variants within <italic toggle="yes">PAX3</italic> or deletion of the entire gene result in haploinsufficiency. Pathogenic variants within <italic toggle="yes">PAX3</italic> causing Waardenburg syndrome type I (WS1) were first described in 1992 [<xref ref-type="bibr" rid="ws1.REF.baldwin.1992.637">Baldwin et al 1992</xref>, <xref ref-type="bibr" rid="ws1.REF.tassabehji.1992.635">Tassabehji et al 1992</xref>]. Multiple abnormal variants in different populations [<xref ref-type="bibr" rid="ws1.REF.chen.2010.70">Chen et al 2010</xref>, <xref ref-type="bibr" rid="ws1.REF.pingault.2010.391">Pingault et al 2010</xref>, <xref ref-type="bibr" rid="ws1.REF.wang.2010.1146">Wang et al 2010</xref>, <xref ref-type="bibr" rid="ws1.REF.matsunaga.2013.345">Matsunaga et al 2013</xref>] &#x02013; including multiple pathogenic variants within <italic toggle="yes">PAX3</italic> causing WS1, WS1 with spina bifida, WS3, and craniofacial-deafness-hand syndrome (CDHS) (OMIM <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/122880">122880</ext-link>) &#x02013; have been described (see <xref ref-type="sec" rid="ws1.Clinical_Description">Clinical Description</xref>, <xref ref-type="sec" rid="ws1.Differential_Diagnosis">Differential Diagnosis</xref>, and <xref ref-type="sec" rid="ws1.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref>).</p>
          <p><bold>Normal gene product.</bold>
<xref ref-type="bibr" rid="ws1.REF.bondurand.2000.1907">Bondurand et al [2000]</xref> showed that an interaction among <italic toggle="yes">PAX3</italic>, <italic toggle="yes">SOX10</italic>, and <italic toggle="yes">MITF</italic> in the regulation of melanocyte development affects a molecular pathway leading to the auditory-pigmentary abnormalities seen in WS. Given the marked variability in expression of phenotypic features among family members having the same pathogenic variant, the potential role of modifier genes may be significant. <xref ref-type="bibr" rid="ws1.REF.satojin.2008.1155">Sato-Jin et al [2008]</xref> further added to this research by demonstrating that <italic toggle="yes">EDNRB</italic> expression was dependent on <italic toggle="yes">MITF</italic>. In addition, they found that <italic toggle="yes">EDN</italic> directly stimulates the expression of melanocytic pigmentation in an <italic toggle="yes">MITF</italic>-dependent fashion.</p>
          <p><bold>Abnormal gene product.</bold> The paired box protein Pax3 is an essential regulator of muscle and neural crest-derived cell types, including melanocytes. Analysis of <italic toggle="yes">PAX3</italic> pathogenic variants observed in WS1 revealed varying ability of <italic toggle="yes">PAX3</italic> to bind to and regulate reporter genes fused to either the <italic toggle="yes">MITF</italic> or TRP-1 (tyrosinase-related protein 1) promoters [<xref ref-type="bibr" rid="ws1.REF.corry.2005.427">Corry &#x00026; Underhill 2005</xref>]. Hence, Pax3 appears to be able to regulate target genes through alternate modes of DNA recognition that are dependent on the specific pathogenic variants. <xref ref-type="bibr" rid="ws1.REF.corry.2008.1825">Corry et al [2008]</xref> showed that the subnuclear localization and altered mobility of the mutated Pax3 protein is a key determinant in its dysfunction. <xref ref-type="bibr" rid="ws1.REF.birrane.2009.1148">Birrane et al [2009]</xref> further demonstrated that certain <italic toggle="yes">PAX3</italic> pathogenic missense variants could destabilize the folding of the Pax3 homeodomain, whereas others affect its interaction with DNA. <xref ref-type="bibr" rid="ws1.REF.wu.2015.20556">Wu et al [2015]</xref> have examined the loading of <italic toggle="yes">PAX3</italic> on mitotic chromosomes in zebrafish and suggest that mutated <italic toggle="yes">PAX3</italic> proteins have dominant negative effects.</p>
          <sec id="ws1.Cancer_and_Benign_Tumors">
            <title>Cancer and Benign Tumors</title>
            <p>Somatic <italic toggle="yes">PAX3</italic> variants have been observed in alveolar rhabdomyosarcoma. <italic toggle="yes">PAX3</italic> can fuse with <italic toggle="yes">FKHR</italic>, this fusion creating a gain of function that results in alveolar rhabdomyosarcoma [<xref ref-type="bibr" rid="ws1.REF.wang.2008.2281">Wang et al 2008</xref>]. Individuals with alveolar rhabdomyosarcoma resulting from this mechanism do not have WS1.</p>
          </sec>
        </sec>
      </sec>
      <sec id="ws1.References">
        <title>References</title>
        <sec id="ws1.Published_GuidelinesConsensus_Statem">
          <title>Published Guidelines/Consensus Statements</title>
          <ref-list id="ws1.Published_GuidelinesConsensus_Statem.reflist0">
            <ref id="ws1.REF1">
              <mixed-citation publication-type="web">American College of Medical Genetics. Statement on universal newborn hearing screening. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.acmg.net/StaticContent/StaticPages/Universal_Hearing.pdf">online</ext-link>. 2000. Accessed 3-22-2017.</mixed-citation>
            </ref>
            <ref id="ws1.REF2">
              <mixed-citation publication-type="web">American College of Medical Genetics Genetic Evaluation of Congenital Hearing Loss Expert Panel. Genetics evaluation guidelines for the etiologic diagnosis of congenital hearing loss. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3110944/">online</ext-link>. 2002. Accessed 3-22-2017.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="ws1.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="ws1.Literature_Cited.reflist0">
            <ref id="ws1.REF.amirsalari.2012.2179">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Amirsalari</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ajallouyean</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saburi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haddadi Fard</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Abed</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghazavi</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Cochlear implantation outcomes in children with Waardenburg syndrome.</article-title>
                <source>Eur Arch Otorhinolaryngol.</source>
                <volume>269</volume>
                <fpage>2179</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">22159916</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.asher.1996.30">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Asher</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sommer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morell</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedman</surname>
                    <given-names>TB</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Missense mutation in the paired domain of PAX3 causes craniofacial-deafness-hand syndrome.</article-title>
                <source>Hum Mutat</source>
                <volume>7</volume>
                <fpage>30</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">8664898</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.baldwin.1992.637">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Baldwin</surname>
                    <given-names>CT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hoth</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amos</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>da-Silva</surname>
                    <given-names>EO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milunsky</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>1992</year>
                <article-title>An exonic mutation in the HuP2 paired domain gene causes Waardenburg's syndrome.</article-title>
                <source>Nature</source>
                <volume>355</volume>
                <fpage>637</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">1347149</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.birrane.2009.1148">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Birrane</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soni</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ladias</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Structural basis for DNA recognition by the human PAX3 homeodomain.</article-title>
                <source>Biochemistry</source>
                <volume>48</volume>
                <fpage>1148</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">19199574</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.black.2001.188">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Black</surname>
                    <given-names>FO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pesznecker</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allen</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gianna</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>A vestibular phenotype for Waardenburg syndrome?</article-title>
                <source>Otol Neurotol</source>
                <volume>22</volume>
                <fpage>188</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">11300267</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.bondurand.2007.1169">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bondurand</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dastot-Le Moal</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stanchina</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collot</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baral</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marlin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Attie-Bitach</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giurgea</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skopinski</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reardon</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toutain</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarda</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Echaieb</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lackmy-Port-Lis</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Touraine</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amiel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goossens</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pingault</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Deletions at the SOX10 gene locus cause Waardenburg syndrome types 2 and 4.</article-title>
                <source>Am J Hum Genet</source>
                <volume>81</volume>
                <fpage>1169</fpage>
                <lpage>85</lpage>
                <pub-id pub-id-type="pmid">17999358</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.bondurand.2000.1907">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bondurand</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pingault</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goerich</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lemort</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sock</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caignec</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wegner</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goossens</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome.</article-title>
                <source>Hum Mol Genet</source>
                <volume>9</volume>
                <fpage>1907</fpage>
                <lpage>17</lpage>
                <pub-id pub-id-type="pmid">10942418</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.brezo.2014.1512">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Brezo</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lam</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilain</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quintero-Rivera</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Phenotypic variability in Waardenburg syndrome resulting from a 22q12.3-q13.1 microdeletion involving SOX10.</article-title>
                <source>Am J Med Genet Part A</source>
                <volume>164A</volume>
                <fpage>1512</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">24715709</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.chaoui.2011.1436">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chaoui</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Watanabe</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Touraine</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baral</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goossens</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pingault</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bondurand</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Identification and functional analysis of SOX10 missense mutations in different subtypes of Waardenburg syndrome.</article-title>
                <source>Hum Mut</source>
                <volume>32</volume>
                <fpage>1436</fpage>
                <lpage>49</lpage>
                <pub-id pub-id-type="pmid">21898658</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.chen.2010.70">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jiang</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xie</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mei</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>He</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hu</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xia</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feng</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Novel mutations of PAX3, MITF, and SOX10 genes in Chinese patients with type I or type II Waardenburg syndrome.</article-title>
                <source>Biochem Biophys Res Commun</source>
                <volume>397</volume>
                <fpage>70</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">20478267</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.corry.2008.1825">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Corry</surname>
                    <given-names>GN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hendzel</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Underhill</surname>
                    <given-names>DA</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Subnuclear localization and mobility are key indicators of PAX3 dysfunction in Waardenburg syndrome.</article-title>
                <source>Hum Mol Genet</source>
                <volume>17</volume>
                <fpage>1825</fpage>
                <lpage>37</lpage>
                <pub-id pub-id-type="pmid">18325909</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.corry.2005.427">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Corry</surname>
                    <given-names>GN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Underhill</surname>
                    <given-names>DA</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Pax3 target gene recognition occurs through distinct modes that are differentially affected by disease-associated mutations.</article-title>
                <source>Pigment Cell Res</source>
                <volume>18</volume>
                <fpage>427</fpage>
                <lpage>38</lpage>
                <pub-id pub-id-type="pmid">16280008</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.de_sousa_andrade.2012.1375">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>de Sousa Andrade</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Monteiro</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martins</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alves</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santos Silva</surname>
                    <given-names>LF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quadros</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ribeiro</surname>
                    <given-names>CA</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Cochlear implant rehabilitation outcomes in Waardenburg syndrome children.</article-title>
                <source>Int J Pediatr Otorhinolaryngol</source>
                <volume>76</volume>
                <fpage>1375</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">22784507</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.destefano.1998.499">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>DeStefano</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cupples</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arnos</surname>
                    <given-names>KS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Asher</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baldwin</surname>
                    <given-names>CT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blanton</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carey</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>da Silva</surname>
                    <given-names>EO</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedman</surname>
                    <given-names>TB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greenberg</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lalwani</surname>
                    <given-names>AK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milunsky</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nance</surname>
                    <given-names>WE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pandya</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramesar</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Read</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tassabejhi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilcox</surname>
                    <given-names>ER</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>LA</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Correlation between Waardenburg syndrome phenotype and genotype in a population of individuals with identified PAX3 mutations.</article-title>
                <source>Hum Genet</source>
                <volume>102</volume>
                <fpage>499</fpage>
                <lpage>506</lpage>
                <pub-id pub-id-type="pmid">9654197</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.elmalehberg_s.2013.1257">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Elmaleh-Berg&#x000e8;s</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumann</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Noel-Petroff</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sekkal</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Couloigner</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devriendt</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wilson</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marlin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sebag</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pingault</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Spectrum of temporal bone abnormalities in patients with Waardenburg syndrome and SOX10 mutations.</article-title>
                <source>AJNR Am J Neuroradiol.</source>
                <volume>34</volume>
                <fpage>1257</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">23237859</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.farrer.1992.902">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Farrer</surname>
                    <given-names>LA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grundfast</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amos</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arnos</surname>
                    <given-names>KS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Asher</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beighton</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diehl</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fex</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Foy</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Friedman</surname>
                    <given-names>TB</given-names>
                  </name>
                  <etal/>
                </person-group>
                <year>1992</year>
                <article-title>Waardenburg syndrome (WS) type I is caused by defects at multiple loci, one of which is near ALPP on chromosome 2: first report of the WS consortium.</article-title>
                <source>Am J Hum Genet</source>
                <volume>50</volume>
                <fpage>902</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">1349198</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.fleming.1998.2107">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Fleming</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Copp</surname>
                    <given-names>AJ</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Embryonic folate metabolism and mouse neural tube defects.</article-title>
                <source>Science</source>
                <volume>280</volume>
                <fpage>2107</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">9641914</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.gad.2008.1880">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gad</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laurino</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maravilla</surname>
                    <given-names>KR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsushita</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Raskind</surname>
                    <given-names>WH</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Sensorineural deafness, distinctive facial features, and abnormal cranial bones: a new variant of Waardenburg syndrome?</article-title>
                <source>Am J Med Genet A.</source>
                <volume>146A</volume>
                <fpage>1880</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">18553554</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.hoth.1993.455">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hoth</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milunsky</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lipsky</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sheffer</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clarren</surname>
                    <given-names>SK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baldwin</surname>
                    <given-names>CT</given-names>
                  </name>
                </person-group>
                <year>1993</year>
                <article-title>Mutations in the paired domain of the human PAX3 gene cause Klein-Waardenburg syndrome (WS-III) as well as Waardenburg syndrome type I (WS-I).</article-title>
                <source>Am J Hum Genet</source>
                <volume>52</volume>
                <fpage>455</fpage>
                <lpage>62</lpage>
                <pub-id pub-id-type="pmid">8447316</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.iso.2008.2162">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Iso</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukami</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horikawa</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Azuma</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawashiro</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ogata</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>SOX10 mutation in Waardenburg syndrome type II.</article-title>
                <source>Am J Med Genet A</source>
                <volume>146A</volume>
                <fpage>2162</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">18627047</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.jan.2008.744">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jan</surname>
                    <given-names>IA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stroedter</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haq</surname>
                    <given-names>AU</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Din</surname>
                    <given-names>ZU</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Association of Shah-Waardenburgh syndrome: a review of 6 cases.</article-title>
                <source>J Pediatr Surg</source>
                <volume>43</volume>
                <fpage>744</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">18405726</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.jones.1975.84">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>KL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>DW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harvey</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hall</surname>
                    <given-names>BD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quan</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>1975</year>
                <article-title>Older paternal age and fresh gene mutation: data on additional disorders.</article-title>
                <source>J Pediatr</source>
                <volume>86</volume>
                <fpage>84</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">1110452</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.kapur.1991.194">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kapur</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karam</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>1991</year>
                <article-title>Germ-line mosaicism in Waardenburg syndrome.</article-title>
                <source>Clin Genet</source>
                <volume>39</volume>
                <fpage>194</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">2036740</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.koyama.2016.2854736">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Koyama</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kashio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakata</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsutsumiuchi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsumoto</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Karino</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kakigi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iwasaki</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamasoba</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2016</year>
                <article-title>The hearing outcomes of cochlear implantation in Waardenburg syndrome.</article-title>
                <source>Biomed Res Int.</source>
                <volume>2016</volume>
                <fpage>2854736</fpage>
                <pub-id pub-id-type="pmid">27376080</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.kujat.2007.155">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kujat</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Veith</surname>
                    <given-names>VP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faber</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Froster</surname>
                    <given-names>UG</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Prenatal diagnosis and genetic counseling in a case of spina bifida in a family with Waardenburg syndrome type I.</article-title>
                <source>Fetal Diagn Ther</source>
                <volume>22</volume>
                <fpage>155</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">17139175</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.l_ger.2012.584">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>L&#x000e9;ger</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balguerie</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goldenberg</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drouin-Garraud</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cabot</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amstutz-Montadert</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joly</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bodereau</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holder-Espinasse</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jamieson</surname>
                    <given-names>RV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krause</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumann</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nunes</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dollfus</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goossens</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pingault</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Novel and recurrent non-truncating mutations of the MITF basic domain: genotypic and phenotypic variations in Waardenburg and Tietz syndromes.</article-title>
                <source>Eur J Hum Genet</source>
                <volume>20</volume>
                <fpage>584</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">22258527</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.lemay.2015.493">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lemay</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guyot</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tremblay</surname>
                    <given-names>&#x000c9;</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dionne-Laporte</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spiegelman</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Henrion</surname>
                    <given-names>&#x000c9;</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diallo</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Marco</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merello</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Massicotte</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D&#x000e9;silets</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michaud</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouleau</surname>
                    <given-names>GA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Capra</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kibar</surname>
                    <given-names>Z</given-names>
                  </name>
                </person-group>
                <article-title>Loss-of-function de novo mutations play an important role in severe human neural tube defects.</article-title>
                <source>J Med Genet.</source>
                <year>2015</year>
                <volume>52</volume>
                <fpage>493</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">25805808</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.liu.1995.95">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>XZ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newton</surname>
                    <given-names>VE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Read</surname>
                    <given-names>AP</given-names>
                  </name>
                </person-group>
                <year>1995</year>
                <article-title>Waardenburg syndrome type II: phenotypic findings and diagnostic criteria.</article-title>
                <source>Am J Med Genet</source>
                <volume>55</volume>
                <fpage>95</fpage>
                <lpage>100</lpage>
                <pub-id pub-id-type="pmid">7702105</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.madden.2003.2035">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Madden</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Halsted</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hopkin</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choo</surname>
                    <given-names>DI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benton</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greinwald</surname>
                    <given-names>JH</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Temporal bone abnormalities associated with hearing loss in Waardenburg syndrome.</article-title>
                <source>Laryngoscope</source>
                <volume>113</volume>
                <fpage>2035</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">14603070</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.matsunaga.2013.345">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Matsunaga</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mutai</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Namba</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Morita</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Masuda</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Genetic analysis of PAX3 for diagnosis of Waardenburg syndrome type I.</article-title>
                <source>Acta Otolaryngol</source>
                <volume>133</volume>
                <fpage>345</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">23163891</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.merchant.2001.875">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Merchant</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McKenna</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baldwin</surname>
                    <given-names>CT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milunsky</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nadol</surname>
                    <given-names>JB</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Otopathology in a case of type I Waardenburg's syndrome.</article-title>
                <source>Ann Otol Rhinol Laryngol</source>
                <volume>110</volume>
                <fpage>875</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">11558766</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.milunsky.2007.179">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Milunsky</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maher</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ito</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milunsky</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>The value of MLPA in Waardenburg syndrome.</article-title>
                <source>Genet Test</source>
                <volume>11</volume>
                <fpage>179</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">17627390</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.newton.2002.201">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Newton</surname>
                    <given-names>VE</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Clinical features of the Waardenburg syndromes.</article-title>
                <source>Adv Otorhinolaryngol</source>
                <volume>61</volume>
                <fpage>201</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">12408085</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.ohtani.2006.491">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ohtani</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Skinkai</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horibe</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katayama</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuji</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsushima</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tachibana</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kunieda</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>A deletion in the endothelin-B receptor gene is responsible for the Waardenburg syndrome-like phenotypes of WS4 mice.</article-title>
                <source>Exp Anim</source>
                <volume>55</volume>
                <fpage>491</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">17090968</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.pardono.2003.223">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pardono</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Bever</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Ende</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Havrenne</surname>
                    <given-names>PC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iughetti</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maestrelli</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Costa</surname>
                    <given-names>F O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Richieri-Costa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frota-Pessoa</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Otto</surname>
                    <given-names>PA</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Waardenburg syndrome: clinical differentiation between types I and II.</article-title>
                <source>Am J Med Genet A</source>
                <volume>117A</volume>
                <fpage>223</fpage>
                <lpage>35</lpage>
                <pub-id pub-id-type="pmid">12599185</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.pingault.2010.391">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pingault</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ente</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dastot-Le Moal</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goossens</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marlin</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bondurand</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Review and update of mutations causing Waardenburg syndrome.</article-title>
                <source>Hum Mutat</source>
                <volume>31</volume>
                <fpage>391</fpage>
                <lpage>406</lpage>
                <pub-id pub-id-type="pmid">20127975</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.preus.1983.383">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Preus</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Linstrom</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Polomeno</surname>
                    <given-names>RC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milot</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>1983</year>
                <article-title>Waardenburg syndrome--penetrance of major signs.</article-title>
                <source>Am J Med Genet</source>
                <volume>15</volume>
                <fpage>383</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">6881207</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.s_nchezmart_n.2003.125">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>S&#x000e1;nchez-Mart&#x000ed;n</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;rez-Losada</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodr&#x000ed;guez-Garc&#x000ed;a</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonz&#x000e1;lez-S&#x000e1;nchez</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Korf</surname>
                    <given-names>BR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuster</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moss</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spritz</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>S&#x000e1;nchez-Garc&#x000ed;a</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Deletion of the SLUG (SNAI2) gene results in human piebaldism.</article-title>
                <source>Am J Med Genet A</source>
                <volume>122A</volume>
                <fpage>125</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">12955764</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.satojin.2008.1155">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sato-Jin</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishimura</surname>
                    <given-names>EK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Akasaka</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huber</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakano</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miller</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Du</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanada</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sawamura</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fisher</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imokawa</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Epistatic connections between micropthalmia-associated transcription factor and endothelin signaling in Waardenburg syndrome and other pigmentary disorders.</article-title>
                <source>FASEB J</source>
                <volume>22</volume>
                <fpage>1155</fpage>
                <lpage>68</lpage>
                <pub-id pub-id-type="pmid">18039926</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.shields.2013.1167">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shields</surname>
                    <given-names>CL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nickerson</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Al-Dahmash</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shields</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Waardenburg syndrome: iris and choroidal hypopigmentation: findings on anterior and posterior segment imaging.</article-title>
                <source>JAMA Ophthalmol</source>
                <volume>131</volume>
                <fpage>1167</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">23868078</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.sommer.2003.91">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sommer</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bartholomew</surname>
                    <given-names>DW</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Craniofacial-deafness-hand syndrome revisited.</article-title>
                <source>Am J Med Genet A</source>
                <volume>123A</volume>
                <fpage>91</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">14556253</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.sznajer.2008.1038">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sznajer</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coldea</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meire</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delpierre</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sekhara</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Touraine</surname>
                    <given-names>RL</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>A de novo SOX10 mutation causing severe type 4 Waardenburg syndrome without Hirschsprung disease.</article-title>
                <source>Am J Med Genet A</source>
                <volume>146A</volume>
                <fpage>1038</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">18348267</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.tamayo.2008.1026">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tamayo</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gelvez</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rodriguez</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Florez</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Varon</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Medina</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernal</surname>
                    <given-names>JE</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Screening program for Waardenburg syndrome in Colombia: clinical definition and phenotypic variability.</article-title>
                <source>Am J Med Genet A</source>
                <volume>146A</volume>
                <fpage>1026</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">18241065</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.tassabehji.1992.635">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Tassabehji</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Read</surname>
                    <given-names>AP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newton</surname>
                    <given-names>VE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Harris</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Balling</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gruss</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strachan</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>1992</year>
                <article-title>Waardenburg's syndrome patients have mutations in the human homologue of the Pax-3 paired box gene.</article-title>
                <source>Nature</source>
                <volume>355</volume>
                <fpage>635</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">1347148</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.waardenburg.1951.195">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Waardenburg</surname>
                    <given-names>PJ</given-names>
                  </name>
                </person-group>
                <year>1951</year>
                <article-title>A new syndrome combining developmental anomalies of the eyelids, eyebrows and nose root with pigmentary defects of the iris and head hair and with congenital deafness.</article-title>
                <source>Am J Hum Genet</source>
                <volume>3</volume>
                <fpage>195</fpage>
                <lpage>253</lpage>
                <pub-id pub-id-type="pmid">14902764</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.wang.2010.1146">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xiao</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guo</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>Q</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>PAX3 mutations and clinical characteristics in Chinese patients with Waardenburg syndrome type 1.</article-title>
                <source>Mol Vis</source>
                <volume>16</volume>
                <fpage>1146</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">20664692</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.wang.2008.2281">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fang</surname>
                    <given-names>WH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krupinski</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kumar</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slevin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kumar</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Pax genes in embryogenesis and oncogenesis.</article-title>
                <source>J Cell Mol Med</source>
                <volume>12</volume>
                <fpage>2281</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">18627422</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.wildhardt.2013">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wildhardt</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zirn</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Graul-Neumann</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wechtenbruch</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suckfull</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buske</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bohring</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kubisch</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vogt</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strobl-Wildemann</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greally</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bartsch</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Steinberger</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <article-title>Spectrum of novel mutations found in Waardenburg syndrome types 1 and 2: implications for molecular genetic diagnostics.</article-title>
                <source>BMJ Open.</source>
                <year>2013</year>
                <volume>3</volume>
                <issue>3</issue>
                <comment/>
                <pub-id pub-id-type="doi">10.1136/bmjopen-2012-001917</pub-id>
                <pub-id pub-id-type="pmid">23512835</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.wollnik.2003.42">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wollnik</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tukel</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uyguner</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghanbari</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kayserili</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Emiroglu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yuksel-Apak</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Homozygous and heterozygous inheritance of PAX3 mutations causes different types of Waardenburg syndrome.</article-title>
                <source>Am J Med Genet A</source>
                <volume>122A</volume>
                <fpage>42</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">12949970</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.wu.2015.20556">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>TF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yao</surname>
                    <given-names>YL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lai</surname>
                    <given-names>IL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lai</surname>
                    <given-names>CC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>PL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>WM</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Loading of PAX3 to Mitotic Chromosomes Is Mediated by Arginine Methylation and Associated with Waardenburg Syndrome.</article-title>
                <source>J Biol Chem.</source>
                <volume>290</volume>
                <fpage>20556</fpage>
                <lpage>64</lpage>
                <pub-id pub-id-type="pmid">26149688</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.yang.2013.e77149">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dai</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kang</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhou</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yuan</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Genetic and phenotypic heterogeneity in Chinese patients with Waardenburg syndrome type II.</article-title>
                <source>PLoS One.</source>
                <volume>8</volume>
                <fpage>e77149</fpage>
                <pub-id pub-id-type="pmid">24194866</pub-id>
              </element-citation>
            </ref>
            <ref id="ws1.REF.zhang.2012.491">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Luo</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>An</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sun</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mei</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>He</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jiang</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jiang</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xia</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feng</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Functional analysis of Waardenburg syndrome-associated PAX3 and SOX10 mutations: report of a dominant-negative SOX10 mutation in Waardenburg syndrome type II.</article-title>
                <source>Hum Genet.</source>
                <volume>131</volume>
                <fpage>491</fpage>
                <lpage>503</lpage>
                <pub-id pub-id-type="pmid">21965087</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="ws1.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="ws1.Suggested_Reading.reflist0">
            <ref id="ws1.REF.vicenteduenas.2005">
              <mixed-citation publication-type="web">Vicente-Duenas C, Bermejo-Rodriguez C, Perez-Caro M, Gonzalez-Herrero I, Sanchez-Martin M, Sanchez-Garcia I. Waardenburg syndrome (WS). Atlas of Genetics and Cytogenetics Oncology and Haematology. Available <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://atlasgeneticsoncology.org/Kprones/WaardenburgID10089.html">online</ext-link>. 2005. Accessed 3-22-2017.</mixed-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="ws1.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="ws1.Author_Notes">
          <title>Author Notes</title>
          <p>Dr. Milunsky was previously a Professor in the Department of Pediatrics, Genetics, and Genomics at Boston University School of Medicine. He is currently the Co-Director of the Center for Human Genetics, Inc (Cambridge, MA), where he also serves as Senior Molecular Director and Director of Clinical Genetics. His interest in Waardenburg syndrome predates the identification of <italic toggle="yes">PAX3</italic>, when he was involved in gene mapping of several families with WS1.</p>
        </sec>
        <sec id="ws1.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>4 May 2017 (sw) Revision: <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="ws1-W_index_calculator.xlsx" content-type="local-data">W index calculator tool</inline-supplementary-material> added</p>
            </list-item>
            <list-item>
              <p>12 January 2017 (sw) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>7 August 2014 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>29 December 2011 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>4 August 2009 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>19 April 2007 (jm) Revision: deletion/duplication analysis clinically available</p>
            </list-item>
            <list-item>
              <p>17 January 2006 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>22 October 2003 (me) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>30 July 2001 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>12 February 2001 (jm) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
